Selecting High-risk Early Breast Cancer Patients: What to Add to the Number of Metastatic Nodes?

European Journal of Cancer

Volumn 32, Issue 1, 1996, Pages 41-46

  Perrone, F ^b   Carlomagno, C ^b   Lauria, R ^b   De Laurentiis, M ^b   Morabito, A ^b   Panico, L ^b   Pettinato, G ^b   Petrella, G ^b   Gallo, C ^a   Bianco, A R ^b   De Placido, S ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE

Author keywords

Early breast cancer; Fascia invasion; Lymph node metastasis; Nipple invasion; Prognostic factors; pTNM; Skin invasion; Tumour size

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NIPPLE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SKIN METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NIPPLES; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 0029866607     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00442-4     Document Type: Article

References (16)

1. Antman KH, Souhami RL. High-dose chemotherapy in solid tumors. Ann Oncol 1993, 4, S29-S44.
2. Antman KH. Dose intensive adjuvant treatment in breast cancer. ASCO Educational Book 1994, 80-85.
3. Ciatto S, Cecchini S, Iossa A, Grazzini G. T category and operable breast cancer prognosis. Tumori 1989, 75, 18-22.
4. Fisher ER, Costantino J, Fisher B, Redmond C, and collaborating NSABP investigators. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Cancer 1993, 71, 2141-2150.
5. Bianco AR, De Placido S, Gallo C, et al. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study. Lancet 1988, ii, 1095-1099.
6. De Placido S, Perrone F, Carlomagno C, et al. CMF vs CMF/EV in the adjuvant treatment of operable breast cancer. A single center randomised trial (Naples GUN-3 Study). Br J Cancer 1995, 71, 1283-1287.
7. Kaplan EL, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958, 53, 457-481.
8. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966, 50, 163-170.
9. Cox DR. Regression models and life table. J R Stat Soc 1972, B34, 187-220.
10. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989, 63, 181-187.
11. American Joint Committee on Cancer. Manual for Staging of Cancer (fourth edition). Philadelphia, J.B. Lippincott, 1992.
12. Sutherland CM, Mather FJ. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment). Cancer 1985, 55, 1389-1397.
13. Sutherland CM, Mather FJ. Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, and/or chest wall attachment) disease with and without positive lymph nodes. Cancer 1986, 57, 622-629.
14. Clayton F, Hopkins CL. Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer 1993, 71, 1780-1790.
15. Morimoto T, Komaki K, Inui K, et al. Involvement of nipple and areola in early breast cancer. Cancer 1985, 55, 2459-2463.
16. Suehiro S, Inai K, Tokuoka S, et al. Involvement of the nipple in early carcinoma of the breast. Surg Gynecol Obstetrics 1989, 168, 244-248.